Evaluation of a new defibrillation pathway: tongue-epigastric/tongue-apex route. II. Impedance characteristics in human subjects

An automated device for defibrillation using a vertical shock pathway (tongue-epigastric or tongue-apex) has been developed. The energy requirements for defibrillation using vertical pathways are uncertain and will be determined largely by the impedance of the pathway. The purpose of this study was to determine the impedance characteristics of vertical defibrillation pathways in human subjects. Twenty patients undergoing elective cardioversion of atrial fibrillation or atrial flutter, or both, were studied. Patients received shocks from electrodes placed in tongue-epigastric or tongue-cardiac apex positions. The tongue electrode was a 12 cm2 metal plate fixed to a standard plastic oropharyngeal airway. The epigastric or cardiac apex electrode was a 40 cm2 self-adhesive pad. The electrodes were connected to a standard damped-sinusoidal waveform defibrillator. It was found that the two vertical shock pathways had substantially higher impedance than the standard transthoracic pathway: tongue-epigastric pathway 130 +/- 11 omega (SD), tongue-apex pathway 115 +/- 12 omega, transthoracic pathway 68 +/- 11 omega (p less than 0.05). The higher impedance is probably due to the longer interelectrode distances of vertical pathways: tongue-epigastric 33 +/- 3 cm, tongue-apex 28 +/- 3 cm, transthoracic 23 +/- 3 cm (p less than 0.05). Vertical pathway shocks were successful in the cardioversion of 15 of 20 patients. Four of the five patients in whom vertical shocks were unsuccessful subsequently underwent successful cardioversion by transthoracic shocks; the transthoracic shocks achieved a higher current because of lower impedance of the transthoracic route.(ABSTRACT TRUNCATED AT 250 WORDS)     

Defibrillator electrode-chest wall coupling agents: influence on transthoracic impedance and shock success

The purpose of this study was to determine if the difference in transthoracic impedance produced by different coupling agents affects the success of shocks for defibrillation. Three different coupling agents, Harco pads (Hewlett-Packard), Littman pads (3M) and Redux paste (Hewlett-Packard), were assessed in 10 anesthetized dogs in which ventricular fibrillation was induced by electrical stimulation of the right ventricle. Defibrillation was attempted 15 seconds later, using 50, 100 and 150 joules (selected energy). Actual delivered energy, current, impedance and the percent of the shocks that achieved defibrillation were determined for the three coupling agents. Redux paste gave significantly lower impedance and higher current than the two disposable performed coupling pads tested. Despite this, there were no significant differences in shock success among the three coupling agents. Thus, in this experimental model, over a three-fold energy range, disposable coupling pads were as effective as electrode paste for defibrillation despite the slightly higher impedance of the disposable pads.     

Biphasic versus sequential pulse defibrillation: a direct comparison in pigs.

It has recently been demonstrated that both biphasic and sequential pulse defibrillation shocks are superior to monophasic defibrillation shocks in animals and humans. There is little information directly comparing these two waveforms when pulse characteristics, subject, and total electrode surface area are kept constant. Pigs were randomized in a cross-over design for triplicate determinations of defibrillation threshold using biphasic and sequential pulse shocks and both large and small epicardial electrodes. Anesthetized pigs weighing 18 to 28 kg had sets of defibrillating electrodes (TX-7) with total surface areas of 13 cm2 (group 1, n = 16) and 26 cm2 (group 2, n = 16), respectively, attached to the heart. Leading edge delivered voltage, current, and energy were significantly lower with sequential pulse shocks than with biphasic shocks for both electrode sets (delivered energy means +/- standard error of the mean: 13.3 +/- 1.6 versus 22.4 +/- 3.0 joules, and 9.9 +/- 1.5 versus 14.2 +/- 1.6 joules, respectively). In addition, six of the pigs could not be defibrillated with 900 stored V using biphasic shocks, although all pigs were defibrillated with less than 800 stored V using sequential pulse defibrillation. We conclude that sequential pulse defibrillation using three defibrillating electrodes provides an important current delivery system not matched by biphasic shocks using two electrodes when subject, waveform characteristics, and total electrode surface area are kept constant.     

Experimental evaluation and initial clinical application of new self-adhesive defibrillation electrodes

We evaluated the efficacy of self-adhesive electrode pads for defibrillation and cardioversion in animals and patients. In 11 anesthetized dogs, the success rate of shocks given to terminate electrically-induced ventricular fibrillation was similar for both self-adhesive electrode pads and hand-held electrode paddles; success rate approached 100% at energies of 125-150 joules. Eighty patients undergoing defibrillation or elective cardioversion received shocks from self-adhesive pads. In all but 2 patients defibrillation or cardioversion was achieved at least once using these pads. The pads were equally effective from either apex-anterior or apex-posterior positions. The transthoracic impedance using self-adhesive pads was 75 +/- 21 ohms, similar to transthoracic impedance we previously reported when using standard hand-held paddles. No complications occurred with the use of the pads. We conclude that self-adhesive electrode pads are effective for defibrillation and cardioversion.     

Self-adhesive preapplied electrode pads for defibrillation and cardioversion

The efficacy of self-adhesive electrode pads for defibrillation and cardioversion was assessed in 80 patients who received 267 shocks from self-adhesive pads. In all but two patients, defibrillation or cardioversion was achieved at least once. The pads were equally effective when used in the apex-anterior or apex-posterior position. The transthoracic impedance using self-adhesive pads was 75 +/- 21 ohms (mean +/- standard deviation), which is similar to previously reported transthoracic impedance in defibrillation, using standard hand-held electrode paddles of 67 +/- 36 ohms. It is concluded that self-adhesive electrode pads are effective for defibrillation and cardioversion.     

Open chest defibrillation during cardiac surgery: Energy and current requirements

To define the optimal energy and current for open chest defibrillation of human hearts during cardiac surgery 202 patients were prospectively studied. First-shock delivered energies, determined by the date of surgery, were 5 joules (J) (55 patients), 10 J (87 patients) or 20 J (60 patients). Specially calibrated Datascope defibrillators, which displayed delivered energy and peak current, were used. The first shock resulted in defibrillation in 56 percent of patients receiving a shock of 5 J, 70 percent of patients receiving 10 J and 80 percent of patients receiving 20 J (p <0.01 versus 5 J). If necessary, shocks were repeated at the initial energy level; the success rates of initial plus repeated shocks at the same energy level were: 81 percent of patients receiving 5 J, 93 percent of patients receiving 10 J (p <0.05 versus 5 J) and 92 percent of patients receiving 20 J. Of the 55 patients who initially received a 5 J shock, with additional shocks at higher energy levels if necessary, the lowest current that successfully defibrillated the heart (that is, the threshold current) varied fourfold, ranging from 8 to 34 amperes (mean ± standard deviation 12 ± 5). One patient, who received the highest cumulative energy levels (503 J from 12 shocks, including four shocks of 75 J each), showed evidence of myocardial necrosis (positive technetium scan). Four others who received the next highest cumulative energy levels of 120 to 300 J from multiple shocks of up to 40 J had negative technetium scans. It is concluded that the optimal initial energy for open chest defibrillation is 10 to 20 J, and that this dose may be repeated if necessary. This dose will deflbrillate more than 90 percent of hearts, and is unlikely to cause shock-induced necrosis. Smaller doses (5 J) are less effective, whereas larger doses, especially if repeated many times, can cause myocardial necrosis.     

Current-based versus energy-based ventricular defibrillation: a prospective study

Defibrillation is thought to be mediated by a depolarizing current; however, the present method of defibrillation is based on delivering an empiric dose of energy to all patients. The hypothesis of this study was that for equivalent efficacy rates, a current-based defibrillation method would result in delivering less energy and peak current than would the standard energy-based method. In a group of 86 consecutive patients with ventricular fibrillation, every other patient was prospectively assigned to receive shocks according to method 1 or method 2. Method 1 was current based and delivered successive shocks of 25, 25 and a maximum of 40 A; method 2 was energy based and delivered shocks of 200, 200 and 360 joules. Patients in both groups were similar with respect to age, gender, weight, cardiac diagnosis, ejection fraction, antiarrhythmic therapy, chest circumference, chest depth and transthoracic impedance. Each method had statistically equivalent first shock (79% current-based versus 81% energy-based) and cumulative shock success rates. The mean first shock energy was 120 +/- 30 joules for patients receiving the current-based method and 200 joules for patients receiving energy-based shocks (p = 0.0001). The mean peak current was 24 +/- 2.3 and 33 +/- 5.0 A, respectively (p = 0.0001). Therefore, for equivalent first shock success rates, the energy-based method delivered 67% more energy and 38% more current than the current-based method. High transthoracic impedance (greater than or equal to 90 omega) predicted first shock failure only in patients undergoing defibrillation by the energy-based method (p = 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)     

Transesophageal low-energy synchronous cardioversion of atrial flutter/fibrillation in the dog.

The purpose of this study was to determine the feasibility and efficacy of terminating atrial flutter/fibrillation using low-energy synchronous shocks delivered through a transesophageal catheter in dogs with talc-induced pericarditis. Atrial flutter/fibrillation was induced by employing the pulse train method. The minimum effective cardioversion energy level was compared for three different methods--method A, delivery between a distal esophageal electrode and a proximal esophageal electrode; method B, delivery of shocks through a distal esophageal electrode and a plate placed on the chest; method C, transthoracic cardioversion. The minimum effective cardioversion energy level did not differ significantly between methods A and B (1.30 +/- 0.46 joules versus 1.29 +/- 0.35 joules). Transesophageal cardioversion decreased the defibrillation threshold three- to fourfold from that of conventional transthoracic cardioversion. There were no complications of heart block, ventricular fibrillation, or any pathologic evidence of esophageal injury. Thus transesophageal low-energy synchronous cardioversion is considered a feasible and effective method for the treatment of atrial flutter/fibrillation.     

Transthoracic defibrillation: effect of sternotomy on chest impedance.

The purpose of this study was to determine the effect of sternotomy on transthoracic impedance, a major determinant of current flow and defibrillation success. Transthoracic impedance was determined by using a validated test-pulse technique that does not require actual shocks. Seventeen patients undergoing median sternotomy were studied prospectively. Transthoracic impedance was determined before operation, 3 to 5 days after operation and (in eight patients) greater than or equal to 1 month after operation. When measured using paddle electrodes placed in the standard apex-right parasternal defibrillating position, transthoracic impedance declined after sternotomy in all patients, from 77 +/- 18 to 59 +/- 17 omega (p less than 0.01); smaller declines were demonstrated by using other electrode positions. Transthoracic impedance remained below the preoperative level in the eight patients who underwent a second set of measurements at least 1 month after operation. Six normal subjects not undergoing sternotomy underwent serial transthoracic impedance measurements at least 5 days apart; mean transthoracic impedance did not change. It is concluded that transthoracic impedance declines after sternotomy. At any operator-selected energy level a higher current flow will result after sternotomy; this may facilitate postoperative defibrillation.     

Ventricular defibrillation in the dog using implanted and partially implanted electrode systems

Two totally implanted and two partially implanted electrode systems were studied in 2,100 fibrillation-defibrillation episodes in large anesthetized dogs. In one of the totally implanted systems, two metal disks, 7.6 cm in diameter, were implanted between the pectoralis major muscle and the rib cage, with the right electrode high on the chest and slightly to the right of midline and the left electrode over the apex of the heart. In the other totally implanted system, a unipolar catheter electrode positioned in the right atrium and superior vena cava was used together with a 7.6 cm disk electrode over the apex of the heart. In the partially implanted systems, a unipolar catheter electrode in the right atrium and superior vena cava was used together with either a 7.6 cm disk electrode or a 6.3 by 20.3 cm rectangular sheet electrode placed on the surface of the chest over the apex of the heart. Four types of unidirectional shocks were used in evaluating the twin disk system. Nine types of shocks were used with systems involving the catheter electrode. Derived curves indicate that the 90 percent level of successful defibrillation is achieved with 38 joules on the day of implantation and 54 joules 32 weeks after implantation for the twin disk system, 12 joules on the day of implantation and 19 joules 33 weeks after implantation for the catheter-internal disk system, 15 joules for the catheter-external disk system and 24 joules for the catheter-external sheet system.     

Defibrillation Efficacy Using High-Frequency Switching to Proportion Current Among Simultaneous Shock Pathways

High-Frequency Current-Proportioned Defibrillation. Introduction: Multiple-pathway electrode configurations generally allow improved current distribution over the heart and lower defibrillation thresholds than single-pathway systems. However, current distributions using multiple pathways are largely determined by electrode type and location. We hypothesized that switching the current among multiple pathways at high frequency (HF) could allow the switching duty cycle to control the proportion of time-averaged current flowing in each pathway, thus permitting altered (possibly improved) defibrillation efficacy using the same electrodes and shock waveform. Methods and Results: In dogs, we measured the current (I₅₀) for 50% defibrillation success using catheter electrodes in the right ventricular apex (cathode) and superior vena cava (A-pathway anode) and a subcutaneous patch on the left chest wall (B-pathway anode). In group 1 (N = 7), we measured I₅₀s for shocks that used HF to proportion 10% to 90% of the current to the A-pathway. Shocks with 10% to 30% of the current in the A-pathway had significantly lower I₅₀s than nonproportioned shocks using all three electrodes. However, the resistance differed among single and simultaneous pathways so energy did not necessarily parallel these changes. In group 2 (N = 6), we measured I₅₀s for shocks to the B-pathway alone, for nonproportioned shocks to A and B, and for shocks that proportioned 80% of the current to the B-pathway using either HF, sequential, or amplitude proportioning methods. All proportioning methods had similar ISUs that were significantly lower than the I₅₀ for nonproportioned shocks to A and B and that were comparable to shocks to the B-pathway alone. Conclusions: Shocks with most current proportioned to the B-pathway had lower defibrillation currents than nonproportioned shocks using both pathways. Thus, defibrillation efficacy was changed by HF proportioning without changing the electrodes or shock waveform. These findings suggest that HF proportioning may be a method to improve defibrillation.     

Determinants of defibrillation: prospective analysis of 183 patients

Previous studies have suggested that a number of factors may influence the ability to defibrillate: the transthoracic resistance and resultant current flow, the paddle electrode size, the duration of preshock ventricular fibrillation (VF) and cardiopulmonary resuscitation, metabolic abnormalities, body weight, the shock energy selected, and whether the patient is receiving lidocaine. To examine the effect of these variables, a prospective study was conducted of 183 patients who received direct-current shocks for VF. Overall defibrillation rates approached 90%, even in patients with secondary VF, but rates of successful resuscitation and survival were much lower. Patients who never defibrillated despite multiple shocks had a prolonged duration of cardiopulmonary resuscitation preceding the first shock (21 +/- 14 minutes) and systemic hypoxia and acidosis. These conditions tended to occur in patients who initially had cardiac arrest from causes other than VF: asystole, severe bradycardia and electromechanical dissociation. In such patients, VF developed only as a late event, which was then often unresponsive to attempted defibrillation. The other factors examined were not major determinants of defibrillation.     

Disposable defibrillator electrodes

The transthoracic impedance to direct-current defibrillation discharge of the half-sinusoidal waveform was compared using recently marketed disposable defibrillator electrode pads (SAF-D-FIB and DEFIB-PADS) with electrode paste as the interfaces between the defibrillator paddle electrode and chest wall. Twenty-four mongrel dogs with an average weight of 17.3 kilograms were used. Half were shocked with the defibrillator meter setting at 100 watt-seconds (mean delivered energy, 59 watt-seconds) and half at 400 watt-seconds (mean delivered energy, 205 watt-seconds). Each animal received six shocks with both paste and one of the sets of disposable pads. The sequence of shocks was changed in alternate animals. At a meter setting of 100 watt-seconds, the mean impedance using SAF-D-FIB was 59 +/- 6 ohms compared to 46 +/- 6 ohms with paste (p less than 0.001), while that encountered with DEFIB-PADS was 57 +/- 5 ohms compared to 50 +/- 5 ohms with paste (p less than 0.01). At settings of 400 watt-seconds, the impedances encountered were also significantly higher with the disposable electrode (p less than 0.01). The output of many defibrillators in use today is inadequate for consistent defibrillation of adult patients weighing more than 50 to 80 kilograms. Since a minimal peak current per unit of body weight is required for ventricular defibrillation and since a higher transthoracic impedance results in a lower delivered peak current, one should use the paddle electrode-chest wall interface that results in the lowest impedance to defibrillator discharge. The impedance encountered with disposable electrodes is significantly higher than that encountered with electrode paste. Therefore, we do not recommend the use of these disposable electrodes for defibrillation or elective cardioversion.     

Selecting the Transthoracic Defibrillation Shock Directional Vector Based on VF Amplitude Improves Shock Success

Introduction: Termination of ventricular fibrillation (VF) by a defibrillating shock is more likely to occur when the VF amplitude is larger. We hypothesized that a defibrillation shock would achieve higher success if the shock vector was oriented along the largest of the VF amplitudes measured simultaneously in 3 orthogonal ECG leads, and that this axis could be determined near-instantaneously in real time.
Methods and Results: In 9 closed-chest anesthetized swine, a new directional defibrillation (DD) device was used to simultaneously measure the VF peak amplitudes displayed by 3 orthogonal pairs of defibrillation electrodes: anterior–posterior, lateral–lateral, and superior–inferior. Four shocks at each of 3 energy levels (30 Joules [J], 50 J, and 100 J) were delivered through the electrode pair measuring the largest (LA) and smallest (SA) VF peak amplitude at the time of the shock. The odds of shock success (VF termination followed by a perfusing rhythm) were 5 times more likely when shocks were delivered from the LA electrodes than the SA electrodes (odds ratio 5.10, 95% CI: 1.39, 18.79). At the intermediate energy level of 50 J, shocks delivered through the LA electrode pairs had an almost 9 times higher odds of shock success than 50 J shocks delivered through the SA electrode pairs (68.3% vs 18.9%, P = 0.002) (odds ratio 8.94, 95% CI: 2.59, 30.82). Transthoracic impedance and current did not differ for shocks delivered in the LA versus SA groups.
Conclusion: Choosing the defibrillation directional vector based on the largest VF amplitude improved shock success.     

Automated impedance-based energy adjustment for defibrillation: experimental studies

In defibrillation, current flow depends on the energy selected and the transthoracic impedance. If transthoracic impedance is high, current flow may be inadequate to defibrillate. We developed a method by which high transthoracic impedance is automatically compensated for by an increase in operator-selected energy when impedance is high. Transthoracic impedance was predicted in advance of the first shock by passing a low-level current between the defibrillator electrodes during the defibrillator charge cycle; a microprocessor monitored current flow and determined impedance. In 28 mongrel dogs we manipulated transthoracic impedance by placing glycerin-soaked gauze pads between the paddle electrodes and the chest. If the predicted impedance exceeded a preset value, the delivered energy was automatically increased by 40% or 100%. Using this impedance-based energy adjustment technique, we found significant improvements in current flow and success rate of shocks when energy was automatically increased to compensate for high transthoracic impedance. The use of transthoracic impedance as a basis for energy adjustment appears a promising technique to minimize the hazards of high electrical energy; it allows low-energy shocks in most patients while avoiding inappropriate low energies in patients with high impedance. Clinical trials are justified.     

Superiority of biphasic shocks in the defibrillation of dogs by epicardial patches and catheter electrodes

Currently available internal cardiac defibrillators use a uniphasic, truncated exponential waveform morphology of about 6 msec in duration at an energy level of 23 to 33 joules. To determine if improved defibrillation could be achieved with a different waveform morphology, we implanted 4.5 cm2 titanium patches to the left and right ventricle of 28 dogs. After ventricular fibrillation was induced, defibrillation was attempted using 7, 12, 13, or 17 joules. A 5 msec rectangular uniphasic waveform morphology was compared with a 10 msec rectangular biphasic waveform with the lagging 5 msec pulse of half the amplitude of the leading 5 msec. In an additional seven dogs, a transvenous bipolar catheter was placed with the distal electrode in the right ventricular apex and the proximal electrode in the superior vena cava. Biphasic and uniphasic shocks were compared at 14 joules. In the patch-patch system, the biphasic waveform was superior to the uniphasic waveform at 7 joules (67% versus 35%, p less than 0.001) and at 12 joules (93% versus 78%, p less than 0.001). No statistically significant differences were achieved at 13 joules or 17 joules. In the catheter electrode system with a delivered energy of 14 joules, the biphasic waveform was more effective than the uniphasic waveform (87% versus 27%, p less than 0.001). Manufacturers of automatic implantable defibrillators should consider this information in the design of future automatic implantable defibrillators.     

An Experimental Study of Transvenous Defibrillation Using a Coronary Sinus Catheter

The efficacy of a transvenous defibrillating system, utilizing bipolar right ventricular and coronary sinus catheters was evaluated in 14 normal mongrel dogs. Two groups of seven animals each were studied. During all shocks, the right ventricular apex electrode served as the anode. In both groups, defibrillation was performed using the proximal pole of the right ventricular catheter (superior vena cava), as the cathode served as a control (configuration A). In group 1, a coronary sinus cathode (configuration B) was compared to control. The mean energy at which 50% or more of the shocks were successful was similar for configuration B (20.7 ± 7.9 joules) and for configuration A (18.8 ± 9.4 joules). In group 2, the superior vena cava and coronary sinus electrodes served as a common cathode (configuration C). Mean defibrillation energy at which 50% or more of the shocks was successful was 21.4 ± 9.0 joules for configuration C and 27.1 ± 9.5 joules for configuration A (P < 0.01). Leading edge voltage was similar for all three configurations, hut shock duration was longer for configuration A (11.3 ± 2.8 msec) than configuration B (6.6 ± 1.8 msec) or C (6.1 ± 1.5; P < 0.05). Nonsustained ventricular tachycardia and transient heart block were common, but no damage to the coronary sinus was noted despite the delivery of up to 38 shocks. Conclusions: (1) With the catheter system used, coronary sinus to right ventricular apex defibrillation system offered no advantages over a superior vena cava to right ventricular apex system; (2) A three-electrode system with the high right atrium and coronary sinus serving as the common cathode reduced defibrillation thresholds significantly without any severe short-term adverse consequences; and (3) Improvements in catheter design may make a coronary sinus catheter part of a feasible transvenous defibrillating system.     

Electrode pad size, transthoracic impedance and success of external ventricular defibrillation

Electrode pad size is an important determinant of transthoracic current flow during external countershock. Self-adhesive, dual function electrocardiogram/defibrillator pads were used to assess the effect of electrode pad size on defibrillation success with low energy (200 J) shocks. The study analyzed 123 cardiac arrests due to primary ventricular fibrillation (VF) in 105 patients (74 men, 31 women) ages 40 to 84 years (mean 64). Transthoracic impedance was measured before defibrillation using a low amplitude 30-kHz current passed through the chest by way of the electrocardiogram/defibrillator pads applied anteroanteriorly. Pad diameters were small (8/8 cm) in 26 cardiac arrests, intermediate (8/12 cm) in 63 arrests and large (12/12 cm) in 34 cardiac arrests. Transthoracic impedance decreased with increasing pad size (112 +/- 17 vs 92 +/- 22 vs 72 +/- 14 omega, respectively, p = 0.0001). Only the first episode of primary VF during a cardiac arrest was analyzed. A single shock of 200 J (delivered energy) was successful in 8 of 26 (31%) arrests using small pads, in 40 of 63 (63%) with intermediate pads and in 28 of 34 (82%) with large pads (p = 0.0003). A second 200-J shock increased the cumulative defibrillation rates to 12 of 26 (46%), 50 of 63 (79%) and 33 of 34 (97%), respectively (p less than 0.0001). In primary VF, larger self-adhesive electrocardiogram/defibrillator pads are associated with a lower transthoracic impedance and improved defibrillation success rates with low energy shocks.     

Determinants of successful transthoracic defibrillation and outcome in ventricular fibrillation.

OBJECTIVE--To examine factors determining defibrillation success and outcome in patients with ventricular fibrillation. DESIGN--Observational prospective study of age, sex, transthoracic impedance, site of cardiac arrest, ventricular fibrillation duration and amplitude, primary or secondary ventricular fibrillation, aetiology, number of shocks to correct ventricular fibrillation, and drug treatment. SETTING--A teaching hospital and a mobile coronary care unit with a physician. PATIENTS--70 consecutive patients (50 male, 20 female) mean age 66.5 years. INTERVENTIONS--Before the first countershock was administered transthoracic impedance using a 30 kHz low amplitude AC current passed through 8 cm/12 cm self-adhesive defibrillator electrode pads applied in the anteroapical position was measured. The first two shocks were 200 J delivered energy (low energy) and further shocks of 360 J (high energy) were given if required. MAIN OUTCOME MEASURES--Countershock success and outcome from ventricular fibrillation. RESULTS AND CONCLUSIONS--First shock success was significantly greater in inhospital arrests (37/53) than in out-of-hospital arrests (5/17) and in those receiving antiarrhythmic treatment (13/15, 86.7%) v (27/51, 52.9%). Transthoracic impedance was similar in those who were successfully defibrillated with one or two 200 J shocks (98.7 (26) omega) and those who required one or more 360 J shocks (91.4 (23) omega). Success rates with two 200 J shocks were similar in those patients with "high" transthoracic impedance (that is, greater than 115 omega) and those with transthoracic impedance (less than or equal to 115 omega) (8/12 (67%) v 44/58 (76%]. Fine ventricular fibrillation was significantly more common in the patients with a transthoracic impedance of greater than 95 omega (41% (13/32] than in those with a transthoracic impedance less than or equal to 95 omega (13% (5/38]. Death during arrest was significantly more common in patients who needed high energy shocks (14/18 (78%] than in those who needed low energy shocks (16/52 (31%]. Multiple regression analysis identified ventricular fibrillation with an amplitude of greater than or equal to 0.5 mV, age less than or equal to 70 years, and arrests that needed less than or equal to two shocks for defibrillation, in rank order as independent predictors of survival to discharge.     

Clinical efficacy of dual electrode systems for endocardial cardioversion of ventricular tachycardia: a prospective randomized crossover trial

In order to eliminate the need for epicardial electrodes, two large transvenous catheter electrodes or one catheter and one extrathoracic patch electrode have been proposed as alternative electrode configurations for defibrillation and ventricular tachycardia cardioversion by implantable cardioverter/defibrillators. We compared the efficacy and safety of endocardial shocks delivered through these two electrode systems in man in a prospective randomized crossover study. Twelve patients with sustained ventricular tachycardia and heart disease undergoing electrophysiologic study were evaluated. A transvenous tripolar cardioversion electrode catheter with a large distal defibrillation electrode (surface area, 400 mm2) and proximal defibrillation electrode (surface area, 800 mm2) was positioned in the right ventricular apex with a cutaneous patch electrode placed on the cardiac apex. Sustained ventricular tachycardia was induced at electrophysiologic study. Shocks were delivered using two catheter electrodes only (right ventricular cathode and right atrial anode = method I), and one catheter electrode and cutaneous patch (right ventricular cathode and cutaneous apical patch anode = method II). Synchronized monophasic shocks were delivered using three preselected protocols based on ventricular tachycardia cycle length and morphology. Initial shock energies were 25 joules for polymorphic ventricular tachycardia and ventricular fibrillation, 15 joules for monomorphic rapid ventricular tachycardia (cycle length less than or equal to 300 msec), and 5 joules for monomorphic slow ventricular tachycardia (cycle length greater than 300 msec). Ventricular tachycardia was reinduced and shock energies titrated until cardioversion threshold was obtained. Identical ventricular tachycardia episodes were treated with both methods at each energy level.(ABSTRACT TRUNCATED AT 250 WORDS)